|Listed in category:
Have one to sell?

Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mul..

Condition:
New
Price:
US $39.98
ApproximatelyEUR 36.86
Postage:
US $4.99 (approx EUR 4.60) Economy P&P. See detailsfor postage
Located in: Fairhope, Alabama, United States
Delivery:
Estimated between Thu, 30 May and Sat, 1 Jun to 43230
Delivery time is estimated using our proprietary method which is based on the buyer's proximity to the item location, the delivery service selected, the seller's delivery history and other factors. Delivery times may vary, especially during peak periods.
Returns:
30 days return. Buyer pays for return postage. See details- for more information about returns
Payments:
    

Shop with confidence

eBay Money Back Guarantee
Get the item you ordered or your money back. 

Seller information

Registered as private seller, so consumer rights stemming from EU consumer protection law do not apply. eBay Money Back Guarantee still applies to most purchases.
Seller assumes all responsibility for this listing.
eBay item number:305561153681
Last updated on 13 May, 2024 00:45:24 BSTView all revisionsView all revisions

Item specifics

Condition
New: A new, unread, unused book in perfect condition with no missing or damaged pages. See the ...
Country/Region of Manufacture
United States
ISBN
9780521563086
Publication Year
1996
Type
Textbook
Format
Hardcover
Language
English
Publication Name
Networks of Innovation : Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995
Item Height
0.8in
Author
Louis P. Galambos
Item Length
9.3in
Publisher
Cambridge University Press
Item Width
6.2in
Item Weight
18.6 Oz
Number of Pages
320 Pages

About this product

Product Information

Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals.

Product Identifiers

Publisher
Cambridge University Press
ISBN-10
0521563089
ISBN-13
9780521563086
eBay Product ID (ePID)
469095

Product Key Features

Author
Louis P. Galambos
Publication Name
Networks of Innovation : Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995
Format
Hardcover
Language
English
Publication Year
1996
Type
Textbook
Number of Pages
320 Pages

Dimensions

Item Length
9.3in
Item Height
0.8in
Item Width
6.2in
Item Weight
18.6 Oz

Additional Product Features

As Told to
Sewell, Jane Eliot
Lc Classification Number
Rm281.G35 1997
Reviews
'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.' John Hunt, The Pharmaceutical Journal, "Galambos and Sewell's well-documented book is a valuable and unusual contribution to the history of specialized pharmaceutical endeavor in America, with emphasis on the networking required on the long road leading to each new vaccine." Glenn Sonnedecker, American Historical Review, 'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.'John Hunt, The Pharmaceutical Journal, ‘The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.’John Hunt, The Pharmaceutical Journal, "...best described by its subtitile because of the narrow focus on the chronological history of Merck's vaccine unit." Book Reviews, "Rigorously researched and crisply written, Networks of Innovation....makes a strong case for science-based firms' building and sustaining organizational capabilities to achieve technological innovation as well as to accomodate shifting competitive and regulatory environments." David B. Sicilia, The Journal of American History, "...this is a most impressive work....superb at showing the requisites for successful vaccine innovation. It provides outside observers rare insight into decision making processes at a leading pharmaceutical firm." Marvin Fischbaum, H-Net Reviews, "Networks of Innovation deserves a careful and thoughtful reading by historians of technology because it shows how it is possible to analyze effectively the role of individuals in the process of technological change without losing the insights and rigor that come from sociological and economic theory." W. Bernard Carlson, Technology and Culture
Table of Content
Preface; 1. 1894: 'The foremost medical question of the day'; 2. The Mulford story; 3. A Sharp & Dohme interlude; 4. The virology network and a new programme at Merck, Sharp & Dohme; 5. Hilleman's innovations: first phase, measles-mumps-rubella; 6. Dangerous interlude, Marek's Disease adjuvant 65, the Swine Flu drama; 7. Transforming bacteriology: a second phase, meningitis, pneumonia, haemophilus, influenzae; 8. New networks, new leadership: the Hepatitis B vaccines; 9. Vaccine innovation in the nineties: new strategies, new structures, and public confrontations; A word about sources.
Target Audience
Trade
Topic
United States / 20th Century, Preventive Medicine
Dewey Decimal
615.1/9/00973
Dewey Edition
21
Illustrated
Yes
Genre
Medical, History

Item description from the seller

Morebks2

Morebks2

100% positive Feedback
7.4K items sold
Usually responds within 24 hours

Detailed seller ratings

Average for the last 12 months

Accurate description
5.0
Reasonable postage cost
5.0
Delivery time
5.0
Communication
5.0
Registered as a private seller
Thereby, consumer rights stemming from EU consumer protection law do not apply. eBay buyer protection still applies to most purchases.

Seller Feedback (2,517)

s***s (415)- Feedback left by buyer.
Past month
Verified purchase
Arrived quickly and in perfect condition
0***- (1498)- Feedback left by buyer.
Past month
Verified purchase
Thank you!
d***0 (932)- Feedback left by buyer.
Past month
Verified purchase
Arrived in great condition. Thanks.